نتائج البحث - Takuya Adachi

  • يعرض 1 - 7 نتائج من 7
تنقيح النتائج
  1. 1
    Oxidative Stress Management in Chronic Liver Diseases and Hepatocellular Carcinoma

    Oxidative Stress Management in Chronic Liver Diseases and Hepatocellular Carcinoma حسب Daisuke Uchida, Akinobu Takaki, Atsushi Oyama, Takuya Adachi, Nozomu Wada, Hideki Onishi, Hiroyuki Okada

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan

    Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan حسب Takuya Adachi, Ja-Mun Chong, Noriko Nakajima, Masahiro Sano, Jun Yamazaki, Ippei Miyamoto, Haruka Nishioka, Hidetaka Akita, Yuko Sato, Michiyo Kataoka, Harutaka Katano, Minoru Tobiume, Tsuyoshi Sekizuka, Kentaro Itokawa, Makoto Kuroda, Tadaki Suzuki

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4+ T cells through AMPK activation

    Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4+ T cells through AMPK activation حسب Masahiro Takahara, Akinobu Takaki, Sakiko Hiraoka, Takuya Adachi, Yasuyuki Shimomura, Hiroshi Matsushita, Tien Thi Thuy Nguyen, Kazuko Koike, Airi Ikeda, Shiho Takashima, Yasushi Yamasaki, Toshihiro Inokuchi, Hideaki Kinugasa, Yusaku Sugihara, Keita Harada, Shingo Eikawa, Hidetoshi Morita, Heiichiro Udono, Hiroyuki Okada

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab

    Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab حسب Tatsuya Kikuchi, Yasuto Takeuchi, Kazuhiro Nouso, Kazuya Kariyama, Kenji Kuwaki, Junichi Toshimori, Shota Iwado, Akio Moriya, Hiroaki Hagihara, Hiroyuki Takabatake, Toshifumi Tada, Tetsuya Yasunaka, Masahiro Sakata, Masahiko Sue, Nozomi Miyake, Takuya Adachi, Nozomu Wada, Hideki Onishi, Hidenori Shiraha, Akinobu Takaki, Motoyuki Otsuka

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Evidence-based guidelines for supportive care of patients with Ebola virus disease

    Evidence-based guidelines for supportive care of patients with Ebola virus disease حسب François Lamontagne, Robert Fowler, Neill K. J. Adhikari, Srinivas Murthy, David M. Brett‐Major, Michael Jacobs, Timothy M. Uyeki, Constanza Vallenas, Susan L. Norris, William A. Fischer, Tom Fletcher, Adam C. Levine, Paul L. Reed, Daniel G. Bausch, S Gove, Andrew Hall, Susan Shepherd, Reed Siemieniuk, Marie-Claude Lamah, Rashida Kamara, Phiona Nakyeyune, Moses J Soka, Ama Kyerewaa Edwin, Afeez Abiola Hazzan, Shevin T. Jacob, Mubarak Mustafa Elkarsany, Takuya Adachi, Lynda Benhadj, Christophe Clément, Ian Crozier, Armando García, Steven J. Hoffman, Gordon Guyatt

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection

    Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection حسب Shô Miyamoto, Takara Nishiyama, Akira Ueno, Hyeongki Park, Takayuki Kanno, Naotoshi Nakamura, Seiya Ozono, Kazuyuki Aihara, Kenichiro Takahashi, Yuuki Tsuchihashi, Masahiro Ishikane, Takeshi Arashiro, Shinji Saito, Akira Ainai, Yuichiro Hirata, Shun Iida, Harutaka Katano, Minoru Tobiume, Kenzo Tokunaga, Tsuguto Fujimoto, Michiyo Suzuki, Maki Nagashima, Hidenori Nakagawa, Masashi Narita, Yasuyuki Kato, Hidetoshi Igari, Kaori Fujita, Tatsuo Kato, Kazutoshi Hiyama, Keisuke Shindou, Takuya Adachi, Kazuaki Fukushima, Fukumi Nakamura‐Uchiyama, Ryota Hase, Yukihiro Yoshimura, Masaya Yamato, Yasuhiro Nozaki, Norio Ohmagari, Motoi Suzuki, Tomoya Saito, Shingo Iwami, Tadaki Suzuki

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    New filovirus disease classification and nomenclature

    New filovirus disease classification and nomenclature حسب Jens H. Kuhn, Takuya Adachi, Neill K. J. Adhikari, José Ramón Arribas, Ibrahima Bah, Daniel G. Bausch, Nahid Bhadelia, Matthias Borchert, Arne Broch Brantsæter, David M. Brett‐Major, Timothy Burgess, Daniel S. Chertow, Christopher G. Chute, Theodore J. Cieslak, Robert Colebunders, Ian Crozier, Richard T. Davey, Hilde De Clerck, Rafaël Delgado, Laura Evans, Mosoka Fallah, William A. Fischer, Tom Fletcher, Robert Fowler, Thomas Grünewald, Andy Hall, Angela Hewlett, Andy I. M. Hoepelman, Catherine Houlihan, Giuseppe Ippolito, Shevin T. Jacob, Michael Jacobs, Robert Jakob, Frédérique Jacquérioz, Laurent Kaiser, André C. Kalil, Rashidatu Fouad Kamara, Jimmy Kapetshi, Hans‐Dieter Klenk, Gary Kobinger, Mark G. Kortepeter, Colleen S. Kraft, Thomas Kratz, Henry Kyobe Bosa, Marta Lado, François Lamontagne, H. Cliff Lane, Leslie Lobel, Julius J. Lutwama, G. Marshall Lyon, Moses Massaquoi, Thomas Massaquoi, Aneesh K. Mehta, Vital Mondonge Makuma, Srinivas Murthy, Tonny Seikikongo Musoke, Jean‐Jacques Muyembé‐Tamfum, Phiona Nakyeyune, Carolina Nanclares, Miriam Nanyunja, Justus Nsio-Mbeta, Tim O’Dempsey, Janusz T. Pawęska, C. J. Peters, Peter Piot, C. Rapp, Bertrand Renaud, Bruce S. Ribner, Pardis C. Sabeti, John S. Schieffelin, Werner Slenczka, Moses J Soka, Armand Sprecher, James E. Strong, Robert Swanepoel, Timothy M. Uyeki, Michel Van Herp, Pauline Vetter, David A. Wohl, Timo Wolf, Anja Wolz, Alie Wurie, Zabulon Yoti

    منشور في 2019
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: